Market Overview

UPDATE: Piper Jaffray Raises PT on LHC Group on Q4 Earnings, FY13 EPS Guidance

Related LHCG
Top 4 NASDAQ Stocks In The Home Health Care Industry With The Highest Gross Margin
Moving Average Crossover: Great News for LHC Group (LHCG)? - Tale of the Tape

In a report published Monday, Piper Jaffray reiterated its Overweight rating on LHC Group (NASDAQ: LHCG), and slightly raised its price target from $21.00 to $22.00.

Piper Jaffray noted, “Organic admissions growth of 5.6% was solid and the company continues to receive an increasing amount of inbound calls about hospital partnership opportunities. Although the recently completely Addus Home Health acquisition is expected to be neutral to FY13 earnings, we believe Addus could approach corporate margins in 2014 and accretion could be in the neighborhood of $0.20-$0.25 assuming 100 bps of overall G&A leverage.”

LHC Group closed on Friday at $20.35.

Posted-In: Piper JaffrayAnalyst Color Price Target Analyst Ratings

 

Most Popular

Related Articles (LHCG)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters